A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

F-19/F-18 exchange synthesis for a novel [F-18]S1P(3)-radiopharmaceutical




TekijätRokka J, Federico C, Jurttila J, Snellman A, Haaparanta M, Rinne JO, Solin O

KustantajaWILEY-BLACKWELL

Julkaisuvuosi2013

JournalJournal of Labelled Compounds and Radiopharmaceuticals

Tietokannassa oleva lehden nimiJOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS

Lehden akronyymiJ LABELLED COMPD RAD

Vuosikerta56

Numero8

Aloitussivu385

Lopetussivu391

Sivujen määrä7

ISSN0362-4803

DOIhttps://doi.org/10.1002/jlcr.3055


Tiivistelmä
F-19/F-18 isotope exchange is a useful method to label drug molecules containing F-19-fluorine with F-18 without modifying the drug molecule itself. Sphingosine-1-phosphate (S1P) is an important cellular mediator that functions by signaling through cell surface receptors. S1P is involved in several cell responses and may be related to many central nervous system disorders, including neural malfunction in Alzheimer's disease. In this study, [F-18]1-benzyl-N-(3,4-difluorobenzyl)-2-isopropyl-6-(2-methoxyethoxy)-1H-indole-3-carboxamide, a novel F-18-labeled positron emission tomography tracer for the S1P(3) receptor, was successfully synthesized using the F-19/F-18 isotope exchange reaction. Parameters of the reaction kinetics were studied, and correlations between the initial F-18-activity, the amount of precursor, radiochemical yield and specific activity (SA) were determined. Contrary to expectations, high initial F-18-activity decreased the radiochemical yield, and only a minor increase of SA occurred. F-19/F-18 exchange reaction is the use of 2 mu mol precursor with 20GBq of F-18-activity. F-18-activity and F-19/F-18 isotope exchange is used.



Last updated on 2024-26-11 at 14:04